Coronary Artery Calcium Score: What It Shows, When It Helps, and What a CAC of Zero Does Not Mean

Before booking a “heart scan,” ask what its result could change.

A coronary artery calcium scan can provide useful information that a cholesterol panel cannot. But another number is not automatically a better decision. The starting point is whether imaging would resolve a meaningful uncertainty in your prevention plan.

A calcium score is not a blockage score

A CAC scan is a CT examination, usually reported in Agatston units, that measures calcified plaque in the coronary arteries. It does not require intravenous contrast. It is different from coronary CT angiography, which is used to examine coronary anatomy in a different way. [3]

A score does not tell you the percentage by which an artery is narrowed, and it does not capture all noncalcified plaque. The useful distinction is between evidence of calcified coronary atherosclerosis and a complete assessment of every possible cause of heart symptoms. CAC supplies the former, not the latter. [14]

Where it fits in the 2026 U.S. guideline

The 2026 ACC/AHA multisociety dyslipidemia guideline uses PREVENT-ASCVD equations for relevant primary-prevention decisions. It identifies borderline 10-year risk as 3% to below 5%, and intermediate risk as 5% to below 10%. These are not the older risk categories used with the Pooled Cohort Equations. [1]

CAC can help refine decisions in selected men aged 40 or older and women aged 45 or older when uncertainty remains. Those ages are not an instruction for everyone to be scanned. A clinician first considers the estimated risk, additional risk factors, existing treatment indications, and the person's preferences. [1]

An especially useful question is: “Would knowing my CAC score change whether we start treatment, how intensively we treat, or how we discuss the expected benefit?” If not, the scan may add little to the decision.

How to read a result without overreading it

Zero means no coronary calcium was detected by this examination. A positive score documents calcified plaque. As the burden rises, average cardiovascular event risk generally rises, although an individual's risk still depends on the wider clinical picture. [4]

Both the absolute score and its percentile can matter. The percentile compares you with a reference population; it is not the percentage of an artery that is blocked. Reporting categories and treatment thresholds also differ across guidelines, so a table found online should not become a self-treatment algorithm. [9]

A high score deserves a prevention discussion, not a prediction that a heart attack is imminent. It does not, by itself, establish that a stent or invasive angiogram is necessary. [14]

The “power of zero” is not a lifetime guarantee

MESA research supports the favorable near- and medium-term prognosis associated with CAC zero. However, the absence of detectable calcium today does not exclude early plaque or eliminate future risk. [4,5]

This matters when severe hypercholesterolemia, diabetes, smoking, or a strong family history changes the discussion. Some people have reasons for preventive treatment that remain important despite a zero score. A scan should not be used as permission to stop a prescribed medication without reviewing the decision with the treating clinician. [9,16]

A zero is most helpful when it answers the question it was ordered to address. It is much less helpful when it is used to dismiss an unrelated question, such as new chest discomfort.

Symptoms require a different pathway

This article concerns selective risk assessment, not the exclusion of an acute heart attack. New chest pressure, sudden shortness of breath, cold sweating, or other concerning symptoms warrant urgent assessment. In the United States, call 911 for suspected heart attack symptoms rather than waiting to arrange a calcium scan. [13]

What to ask about the test itself

Ask the imaging center about radiation exposure, preparation, and what will happen if an unexpected finding needs follow-up. Report any possibility of pregnancy. Coverage and out-of-pocket cost should be checked before the appointment; coverage is not universal. [3]

For a repeat scan, ask what new decision would depend on it. Research has modeled different rescan intervals after CAC zero, influenced by clinical characteristics. That does not justify automatic annual scanning or a promise of event-free years. [5]

CAC is also not a simple treatment-response scoreboard. In an observational serial-imaging study, statin use was associated with a shift toward denser calcification and less low-attenuation plaque. An increasing calcium score therefore cannot be interpreted as treatment failure on its own. [7]

Does knowing the score improve outcomes?

Risk prediction and outcome improvement are related, but not identical. In the 2025 CAUGHT-CAD randomized trial, 365 participants with a family history of coronary disease were analyzed. A CAC-informed prevention strategy slowed plaque progression over three years. The intervention combined information with preventive care; it did not demonstrate that CT scanning alone reduces mortality for everyone. [8]

Population screening asks yet another question. In the published five-year DANCAVAS analysis, inviting Danish men aged 65–74 to a broader cardiovascular screening program did not significantly reduce all-cause mortality. That program included several tests, so its findings cannot isolate the effect of CAC or settle every selective-use question. [12]

These distinctions support a measured conclusion: CAC is a decision aid for selected people, not a universal health certificate or a replacement for prevention.

Make the next conversation useful

Bring your prior cholesterol results, medication history, family history, and questions about benefits and burdens. Ask your clinician to explain the decision in plain language: what is known now, what remains uncertain, and what the scan would add.

For the laboratory side, continue with LDL-C, ApoB, and Lp(a) and which lab tests matter after 40.

Follow the next question, not the next health trend. Register your interest in the MERHI ONE newsletter and select your preferred editions and updates. Sign-ups are open; email publication has not started.

Evidence before hype. Understanding before action.

General health education only. This article does not provide an individual diagnosis or a medication plan.

References

[1] Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. Circulation. Publicação em 13 de março de 2026. DOI: 10.1161/CIR.0000000000001423. Fonte: https://professional.heart.org/en/science-news/2026-guideline-on-the-management-of-dyslipidemia/top-things-to-know

[3] American College of Radiology / Radiological Society of North America Cardiac CT for Calcium Scoring. RadiologyInfo.org. Revisão indicada na página: 15 de julho de 2026. Fonte: https://www.radiologyinfo.org/en/info/ct_calscoring

[4] Budoff MJ, Young R, Burke G, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J. 2018;39(25):2401–2408. DOI: 10.1093/eurheartj/ehy217. Fonte: https://pubmed.ncbi.nlm.nih.gov/29688297/

[5] Dzaye O, Dardari ZA, Cainzos-Achirica M, et al. Warranty Period of a Calcium Score of Zero: Comprehensive Analysis From MESA. JACC Cardiovasc Imaging. 2021;14(5):990–1002. DOI: 10.1016/j.jcmg.2020.06.048. Fonte: https://pubmed.ncbi.nlm.nih.gov/33129734/

[7] van Rosendael AR, van den Hoogen IJ, Gianni U, et al. Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition. JAMA Cardiol. 2021;6(11):1257–1266. DOI: 10.1001/jamacardio.2021.3055. Fonte: https://jamanetwork.com/journals/jamacardiology/fullarticle/2783117

[8] Nerlekar N, Vasanthakumar S, Whitmore K, et al. Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease: A Randomized Clinical Trial. JAMA. 2025;333(16):1403–1412. DOI: 10.1001/jama.2025.0584. Fonte: https://jamanetwork.com/journals/jama/fullarticle/2831115

[9] Orringer CE, Blaha MJ, Blankstein R, et al. The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction. J Clin Lipidol. 2021;15(1):33–60. Publicação on-line em 2020. DOI: 10.1016/j.jacl.2020.12.005. Fonte: https://www.lipidjournal.com/article/S1933-2874%2820%2930342-1/fulltext

[12] Lindholt JS, Søgaard R, Rasmussen LM, et al. Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial. N Engl J Med. 2022;387:1385–1394. DOI: 10.1056/NEJMoa2208681. Fonte: https://www.nejm.org/doi/full/10.1056/NEJMoa2208681

[13] American Heart Association Warning Signs of a Heart Attack. Recurso oficial para o público. Consultado em 19 de setembro de 2026. Fonte: https://www.heart.org/en/health-topics/heart-attack/warning-signs-of-a-heart-attack

[14] Blaha MJ, Mortensen MB, Kianoush S, Tota-Maharaj R, Cainzos-Achirica M Coronary Artery Calcium Scoring: Is It Time for a Change in Methodology?. JACC Cardiovasc Imaging. 2017;10(8):923–937. DOI: 10.1016/j.jcmg.2017.05.007. Fonte: https://www.jacc.org/doi/10.1016/j.jcmg.2017.05.007

[16] Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. J Am Coll Cardiol. 2019;74(10):e177–e232. DOI: 10.1016/j.jacc.2019.03.010. Fonte: https://www.jacc.org/doi/10.1016/j.jacc.2019.03.010